Atara Biotherapeutics Inc. buy BiotechBee
Start price
01.10.23
/
50%
€1.41
Target price
31.01.26
€3.00
Performance (%)
-74.00%
End price
08.09.24
-
Summary
This prediction is currently being closed. Massive losses of -74.00% have been the result for the BUY prediction by BiotechBee. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Atara Biotherapeutics Inc. | - | - | - |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
According to BiotechBee what are the pros and cons of Atara Biotherapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year